Hey {{first_name|there}} 👋 — here's your high-conviction breakdown for October 26.
TL;DR — Descartes Systems (NASDAQ: DSGX)
The bull case: A textbook quality compounder — Q2 revenue +12% to $201.1M, 94% recurring services revenue, net income +32%, a 47% adjusted EBITDA margin, zero debt, and a disciplined tuck-in M&A machine. The “digital tollbooth” on global trade.
The catch: It’s priced like the gem it is — ~44x trailing / 32x forward earnings, trading near its 52-week high ($97.71), with only ~9% upside to the average target (median just ~4%, and the low target sits below today’s price).
Watch: No near-term catalyst — next earnings (Q3 FY2027) land ~early December. This is a patient, pay-up-for-quality holding, not an explosive breakout.
10 Stocks Powering the AI Buildout
You don't have to invest in AI to profit from it! Each LLM requires a massive amount of specialized technology to stay up and running and even more to keep growing. Our analysts did a deep dive into what it will take for the AI industry to scale simultaneously and found 10 companies that are crucial to the AI infrastructure buildout.
📊 Analyst Ratings
Metric | Figure | Read |
|---|---|---|
Consensus rating | Buy | ~13 Buy / 2 Hold / 0 Sell (14 analysts) |
Avg price target | $102.62 | ~9% upside vs. ~$94 |
Median target | $98 | Only ~4% upside |
Target range | $90 – $126 | Low target is below price |
52-week range | $62.56 – $97.71 | Trading near the high |
Valuation | ~44x / 32x | Trailing / forward P/E |
Consensus in one line: a Buy, but a “pay up for excellence” one. The average target (~$103) implies ~9% upside, but the median is only ~$98 (~4%) and the low target ($90) is already below the current price. The quality is real — and largely priced in.
🏢 Company Overview
Descartes runs the Global Logistics Network (GLN) — the software backbone connecting freight forwarders, carriers, customs brokers, and shippers. Because international trade requires real-time customs filings, routing compliance, and multi-modal tracking, customers can’t unplug it without freezing shipments at the border. That makes revenue exceptionally sticky, with negligible churn.
The economics are elite: 94% of revenue is recurring services (up 13% YoY), gross margin ~78%, and an adjusted EBITDA margin of 47%. It’s a ~$8.0B-cap, debt-free compounder that grows through disciplined, cash-funded tuck-in acquisitions — the two most recent being TAI (freight-broker TMS, ~$99M, Aug 2026) and Extensiv (3PL warehouse management, ~$120M, Sept 2026). The stock has recovered from sub-$70 lows to the mid-$90s, just under its 52-week high.
How Jennifer Aniston’s LolaVie brand grew sales 40% with CTV ads
The DTC beauty category is crowded. To break through, Jennifer Aniston’s brand LolaVie, worked with Roku Ads Manager to easily set up, test, and optimize CTV ad creatives. The campaign helped drive a big lift in sales and customer growth, helping LolaVie break through in the crowded beauty category.
🌍 Macro & Industry Backdrop
Descartes has a genuinely counter-cyclical quality: whether trade is booming or re-routing around disruptions, freight still requires compliance filings and visibility. The fragmentation of global supply chains — friend-shoring, tariffs, sanctions, ESG tracking — increases the need for its software, right in its wheelhouse.
The flip side: freight-volume contractions and slower enterprise software cycles can temper transaction revenue, and it competes with ERP giants (SAP) and point solutions (Project44) in broad TMS. But its customs/compliance moat is where it’s stickiest.
📰 Recent Results & What’s Next
Q2 FY2027 (quarter ended July 31; reported Sept 10) was a clean, high-quality beat:
Revenue: $201.1M, +12% YoY (services revenue +13%, now 94% of total).
Net income: $50.0M, +32% — a 25% net margin.
Adjusted EBITDA: $94.4M, +18% — a 47% margin.
Gross margin: 78%. Operating cash flow: $81.3M, +28%. Zero debt.
⏰ Timing note: Q2 just reported in September, so the next print (Q3 FY2027, quarter ending Oct 31) is ~early December — no imminent catalyst. This is a buy-and-hold compounder, not an event trade.
💼 Insider & Institutional Activity
Institutions own the story. Roughly 77–78% of the float is held by institutions — Manulife, Primecap, Wellington, plus passive index funds — with strong net inflows over the past year. It’s a deep, patient, buy-and-hold base.
Insiders: executive ownership is under 1% of the float; compensation skews to performance equity, with no notable open-market selling — alignment without red flags.
Small Premium. Defined Risk. $1,000+ Potential.
That's the appeal of low-priced options when they're traded with discipline. This free report reveals a repeatable framework for separating high-potential setups from lottery tickets, explains how calls and puts behave with low-cost contracts, and walks through worked examples. Built for traders who demand a process. Get your free copy today.
🏛️ Congressional Trades
Nothing meaningful here — just minor personal-portfolio trades in small-tier disclosures, with no coordinated positioning. A quiet supply-chain software name isn’t on anyone’s political radar.
📊 The Charts: Key Levels
DSGX has recovered strongly from its 2026 lows (sub-$70) and trades mid-$90s, just under its 52-week high of $97.71. The 14-day RSI is neutral (~54–57) — constructive consolidation, not overbought. But note: this is a stock at the top of its range, not breaking out from a base.
Immediate resistance: $96–$98 (recent swing highs / 52-week high)
Major resistance: $102.50–$105 (triple-digit threshold / target zone)
First support: $91.50–$92 (50-day MA / consolidation shelf)
Structural support: $85–$86.50 (200-day MA)
Breakout traders want a daily close above ~$96.50 on volume before expecting a push toward $102. Value/swing traders near $91–$92 get a better entry — but with the stock near its highs and only ~9% to the average target, the risk-reward is tighter than an “asymmetric breakout” framing suggests.
📌 Key Takeaways
Elite business: 94% recurring revenue, 47% EBITDA margin, 78% gross margin, +32% net income, zero debt, disciplined M&A — one of the market’s cleanest compounders.
But fully valued: ~44x trailing / 32x forward, near its 52-week high, with ~9% upside to the average target (median ~4%) and the low target below the price.
Counter-cyclical quality: trade friction increases demand for its compliance software — a real structural tailwind.
No near-term catalyst: next earnings ~early December; patient, pay-up-for-quality holding.
🎯 The Bottom Line
Descartes is a textbook quality compounder — a debt-free, 94%-recurring, high-margin “digital tollbooth” on global trade that gets more essential as supply chains fragment. There’s very little to dislike about the business. The honest caveat is valuation: at ~32x forward earnings, trading near its 52-week high with only single-digit upside to the average analyst target (and the low target already below the price), the market has fully recognized the quality. This is a wonderful business at a fair-to-full price — a “buy the dips and hold for years” name, not an undervalued breakout to chase. If you want one of the steadiest compounders in software, DSGX qualifies; just be patient on entry and keep near-term upside expectations modest.
Disclaimer: Alpha Stocks Daily is for educational and informational purposes only and is not financial, investment, or trading advice. We are not registered investment advisors, and nothing here is a recommendation to buy or sell any security. Always do your own research and consult a licensed professional before investing. Past performance is not indicative of future results.